These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17875747)

  • 1. Ontology, oncology, and preventive economies: developing drugs for cancer prevention.
    Vogel VG
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5227-8. PubMed ID: 17875747
    [No Abstract]   [Full Text] [Related]  

  • 2. American Society of Preventive Oncology Distinguished Career Achievement Lecture 2006--Enjoy the journey: the long and winding road of chemoprevention agent development.
    Meyskens FL
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2038-41. PubMed ID: 17119025
    [No Abstract]   [Full Text] [Related]  

  • 3. Lycopene in cancer prevention and treatment.
    Seren S; Lieberman R; Bayraktar UD; Heath E; Sahin K; Andic F; Kucuk O
    Am J Ther; 2008; 15(1):66-81. PubMed ID: 18223356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention clinical trials: it is time to turn success into progress.
    Brown PH
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1531-2. PubMed ID: 17684123
    [No Abstract]   [Full Text] [Related]  

  • 5. Deal-making trends in oncology.
    Moore K; Walker J
    Nat Rev Drug Discov; 2009 Aug; 8(8):604. PubMed ID: 19644466
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer prevention after cancer: changing the paradigm--a report from the American Society of Preventive Oncology.
    Campo RA; Rowland JH; Irwin ML; Nathan PC; Gritz ER; Kinney AY
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2317-24. PubMed ID: 21908726
    [No Abstract]   [Full Text] [Related]  

  • 7. An audience with...Joseph Bolen. Interview by Bethan Hughes.
    Bolen J
    Nat Rev Drug Discov; 2009 Aug; 8(8):608. PubMed ID: 19644470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current problems in cancer prevention].
    Il'nitskiĭ AP; Zaichenko AI
    Gig Sanit; 1984 Jan; (1):9-13. PubMed ID: 6706178
    [No Abstract]   [Full Text] [Related]  

  • 9. Preventive oncology.
    Rhodes LE
    Lancet; 2004 May; 363(9422):1736-7. PubMed ID: 15158648
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Petrelli NJ; Winer EP; Brahmer J; Dubey S; Smith S; Thomas C; Vahdat LT; Obel J; Vogelzang N; Markman M; Sweetenham JW; Pfister D; Kris MG; Schuchter LM; Sawaya R; Raghavan D; Ganz PA; Kramer B
    J Clin Oncol; 2009 Dec; 27(35):6052-69. PubMed ID: 19901123
    [No Abstract]   [Full Text] [Related]  

  • 11. Current development of clinical oncology in Japan.
    Taguchi T
    Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():21-38. PubMed ID: 11890108
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer chemoprevention--an update on a (still) novel and exciting field of oncology.
    Gescher A; Steward WP
    Eur J Cancer; 2005 Sep; 41(13):1831-2. PubMed ID: 16051480
    [No Abstract]   [Full Text] [Related]  

  • 13. Investing in prevention: what incentive does the pharmaceutical industry have?
    Reynolds T
    J Natl Cancer Inst; 2002 Dec; 94(23):1736-8. PubMed ID: 12464641
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-steroidal anti-inflammatory drugs in cancer prevention and therapy.
    Guadagni F; Ferroni P; Palmirotta R; Del Monte G; Formica V; Roselli M
    Anticancer Res; 2007; 27(5A):3147-62. PubMed ID: 17970056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Chemopreventive Agents: Drug Development Status II.
    J Cell Biochem Suppl; 1996; 26():1-321. PubMed ID: 9221292
    [No Abstract]   [Full Text] [Related]  

  • 16. [Who wants to produce drugs against prostatic cancer?].
    Favrbo K
    Ugeskr Laeger; 2005 May; 167(19):2075-6. PubMed ID: 15960469
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer prevention: an oncologist's perspective.
    Lane M
    Health Values; 1982; 6(3):12-8. PubMed ID: 10255939
    [No Abstract]   [Full Text] [Related]  

  • 18. Preamble to the IARC Handbooks of Cancer Prevention.
    IARC Sci Publ; 1996; (139):1-12. PubMed ID: 8923015
    [No Abstract]   [Full Text] [Related]  

  • 19. Is chemoprevention overrated or underfunded?
    Nelson NJ
    J Natl Cancer Inst; 1996 Jul; 88(14):947-9. PubMed ID: 8667423
    [No Abstract]   [Full Text] [Related]  

  • 20. Epigenome-derived drugs: recent advances and future perspectives.
    Vogiatzi P; Aimola P; Scarano MI; Claudio PP
    Drug News Perspect; 2007 Dec; 20(10):627-33. PubMed ID: 18301797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.